Ironwood Pharmaceuticals (IRWD) Current Leases (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Current Leases across 17 years of filings, most recently posting $3.3 million for Q1 2026.

• Current Leases for Q1 2026 came in at $3.3 million, up 2.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (up 2.0% YoY), and the FY2025 annual result was $3.3 million, up 1.98% from the prior year.
• Current Leases came in at $3.3 million for Q1 2026 at Ironwood Pharmaceuticals, roughly flat from $3.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $3.3 million in Q1 2026 to a low of $3.0 million in Q3 2022.
• The 5-year median for Current Leases is $3.1 million (2024), against an average of $3.1 million.
• Across the five-year window, Current Leases retreated 3.39% in 2022 and advanced 2.02% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Current Leases stood at $3.1 million in 2022, then gained by 1.99% to $3.1 million in 2023, then climbed by 2.02% to $3.2 million in 2024, then advanced by 1.98% to $3.3 million in 2025, then increased by 0.49% to $3.3 million in 2026.
• The last three Current Leases figures came in at $3.3 million (Q1 2026), $3.3 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.